Evolent Health, Inc. (EVH) Stock Score, Valuation & Financial Research
Evolent Health, Inc. is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 20/100.
Quick answer for EVH
Evolent Health, Inc. currently has a Wall Street Score of 20/100. The stored market price is $4.19. Its financial score is 14/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Evolent Health, Inc. does
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, al
EVH financial snapshot
- Wall Street Score:
- 20/100
- Current price:
- $4.19
- Market capitalization:
- $471.3M
- Revenue:
- $2.10B
- Net income:
- $-505.0M
- Free cash flow:
- $4.8M
- Cash:
- $115.7M
- Total debt:
- $970.4M
- EPS:
- -4.49
- Financial score:
- 14/100
- Valuation score:
- 0/100
- Revenue score:
- 32/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $4.8M, showing positive cash generation.
- The balance sheet shows $115.7M of cash versus $970.4M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 14/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research EVH
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.